Miosta S®
A new prescription drug for normalization of protein-energy deficiency (BEN) and stimulation of muscle mass growth in pigs.
Problems faced by animal breeders
8 out of 10
animal breeders believe that the use of hormonal drugs negatively affects the quality of meat, but without them it is impossible to stimulate the growth of muscle mass in animals.
10 out of 10
livestock breeders believe that in order to increase the muscle mass of animals, it is necessary to increase the amount of feed, which significantly increases the cost of their maintenance.
Mechanism of action Miosta S®
It consists in stimulating the production of antibodies in animals against the endogenous peptide LEAP-2 expressed by the liver.
The LEAP-2 mechanism was discovered in 2003. This peptide binds to and blocks the receptor that stimulates the secretion of growth hormone (GHS), and acts as a competitive ghrelin.
The blockade of LEAP-2 in mature animals after the introduction of Miosta S ® leads to an increase in appetite in animals, better digestion of food and an increase in weight gain.
Miosta S ® is not a hormone.
The use of Miosta S® contributes to
Mosta S® is rapidly absorbed from the injection site, reaching a peak concentration in blood plasma 30 minutes after administration, and is slowly excreted from the body. It accumulates in neutrophils and alveolar macrophages, as a result of which its increased concentration in lung tissues is achieved. It is excreted from the body mainly by the kidneys unchanged; the half-life is about 90 hours.
Advantages of using Miosta S®:
Research results
Increase in the absolute weight of pigs during marketing tests, in kg
- Control group
- Who received Mosta S® injections
Research results
Increase in the absolute weight of pigs during marketing tests, in kg
- Control group
- Who received Mosta S® injections